The Food and Drug Administration (FDA) has issued updated information for blood establishments regarding the ongoing coronavirus disease 2019 (COVID-19) pandemic and blood donations.
To date, there have been no reported cases of transfusion-transmitted coronavirus, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The FDA does not recommend using COVID-19 laboratory tests to screen routine blood donors.
Clinicians who are responsible for evaluating prospective blood donors should consider the following:
- Individuals diagnosed with COVID-19 or who are suspected of having COVID-19, and who had symptomatic disease, should refrain from donating blood for at least 14 days after complete resolution of symptoms.
- Individuals who are asymptomatic and had a positive diagnostic test for SARS-CoV-2 should refrain from donating at least 14 days after the date of the positive test result.
- Individuals who have tested positive for SARS-CoV-2 antibodies, but who did not have prior diagnostic testing and never developed symptoms, can donate without a waiting period and without performing a diagnostic test.
- Individuals who received a nonreplicating, inactivated, or mRNA-based COVID-19 vaccine can donate blood without a waiting period, while those who received a live-attenuated viral COVID-19 vaccine, should refrain from donating blood for a short waiting period (eg, 14 days) after receipt of the vaccine.
- If it is uncertain which COVID-19 vaccine was administered, individuals should refrain from donating for a short waiting period (eg, 14 days).
Additionally, blood donors should be in good health and have a normal temperature on the day of donation.
According to the American Red Cross, the pandemic has brought on “unprecedented fluctuations in the supply and demand for blood products,” making it imperative that eligible individuals continue to make and keep appointments for donation.
For more information visit fda.gov.
Updated information for blood establishments regarding the covid-19 pandemic and blood donation. [press release]. Silver Springs, MD: US Food and Drug Administration; January 19, 2021.